Latest News
-
MONTREAL, QC, and TORONTO, ON - November 12, 2009
Health Canada Approves New Treatment for Adults With Type 2 Diabetes
ONGLYZA™ (saxagliptin) approval coincides with new research that shows 91 per cent of Canadians with diabetes are drifting in the management of their disease
-
MONTREAL, QUEBEC — October 6, 2009
Latest Treatment for Schizophrenia Offers Needed Additional Option to Fight Difficult-To-Treat Disease
ABILIFY™ now available in Canada with several benefits: efficacy, good safety, tolerability and neutral impact on weight, cholesterol and blood sugar levels
Categories: Abilify | Schizophrenia
-
MONTREAL, CANADA — September 30, 2009
Erbitux™ Now Available in Ontario and BC for Patients With Advanced Colorectal Cancer
Categories: Erbitux | Metastatic colorectal cancer
